Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1961-1970 of 2876 for cancer

Edit search filters
  1. KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

    Rochester, MN

  2. Do Patients Diagnosed With Cancer Suffer From "scan-itis"?

    Rochester, MN

  3. A Study to Explore Cancer Patient Experiences and Their Decisions About Sharing Genetic Cancer Screening Information with Family Members

    Rochester, MN

  4. MC240508: Genomic Surveillance Of Bladder Cancer

    Scottsdale/Phoenix, AZ

  5. Predicting Responsiveness In Oncology Patients Based On Host Response Evaluation During Anti Cancer Treatments

    Jacksonville, FL

  6. ORACLE: Observation Of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE)

    Rochester, MN

  7. Patient And Caregiver Perspective About Financial Distress Of Cancer Treatment

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Comprehensive Translational Research Platform For Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Metabolite Levels In Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

    Rochester, MN

  10. Asynchronous Skin Cancer Risk Using 3D Total-Body Photograph

    Rochester, MN

.

Mayo Clinic Footer